HIV and HCV discordant injecting partners and their association to drug equipment sharing

References

• Roy E, Alary M, Morissette C, Leclerc P, Boudreau J, Parent R, et al. High hepatitis C virus prevalence and incidence among Canadian intravenous drug users. Int J STD AIDS 2007; 18: 23–7
   PubMed Web of Science ®Google Scholar
• Huo D, Bailey SL, Hershow RC, Ouellet L. Drug use and HIV risk practices of secondary and primary needle exchange users. AIDS Educ Prev 2005; 17: 170–84
   PubMed Web of Science ®Google Scholar
• Des Jarlais DC, Perlis T, Arasteh K, Torian LV, Beatrice S, Milliken J, et al. Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990–2001. AIDS 2005; 19(Suppl 3)S20–5
   PubMedGoogle Scholar
• Koester S, Booth RE, Zhang Y. The prevalence of additional injection-related HIV risk behaviours among injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 12: 202–7
   PubMedGoogle Scholar
• Needle RH, Coyle S, Cesari H, Trotter R, Clatts M, Koester S, et al. HIV risk behaviours associated with the injection process: multiperson use of drug injection equipment and paraphernalia in injection drug user networks. Subst Use Misuse 1998; 33: 2403–23
   PubMed Web of Science ®Google Scholar
• Morissette C Leclerc P Tremblay C. Monitorage des programmes d'accès au matériel stérile d'injection de Montréal-Centre. Rapport synthèse des principales données recueillies entre avril 1999 et mars 2004. Montreal, Canada: Agence de développement de réseaux locaux de services de santé et de services sociaux, June 2004.
   Google Scholar
• Lakon CM, Ennett ST, Norton EC. Mechanisms through which drug, sex partner, and friendship network characteristics relate to risky needle use among high-risk youth and young adults. Soc Sci Med 2006; 63: 2489–99
   PubMed Web of Science ®Google Scholar
• Cox J, De P, Morissette C, Tremblay C, Stephenson R, Allard R, et al. Low perceived benefits and self-efficacy are associated with hepatitis C virus (HCV) infection-related risk among injection drug users. Soc Sci Med 2008; 66: 211–20
   PubMed Web of Science ®Google Scholar
• Catania JA, Kegeles SM, Coates TJ. Towards an understanding of risk behaviour: an AIDS risk reduction model. Health Educ Quarterly 1990; 17: 53–72
   PubMedGoogle Scholar
• Valente TW, Vlahov D. Selective risk taking among needle exchange participants: implications for supplemental interventions. Am J Public Health 2001; 91: 406–11
   PubMed Web of Science ®Google Scholar
• Loxley W, Ovenden C. Friends and lovers: needle sharing in young people in Western Australia. AIDS Care 1995; 7: 337–51
   PubMed Web of Science ®Google Scholar
• Hunter GM, Donoghoe MC, Stimson GV, Rhodes T, Chalmers CP. Changes in the injecting risk behaviour of injecting drug users in London, 1990–1993. AIDS 1995; 9: 493–501
   PubMed Web of Science ®Google Scholar
• Schlumberger MG, Desenclos JC, Papaevangelou G, Richardson SC, Ancelle-Park R. Knowledge of HIV serostatus and preventive behaviour among European injecting drug users: second study. European Community Study Group on HIV in Injecting Drug Users. Eur J Epidemiol 1999; 15: 207–15
   PubMed Web of Science ®Google Scholar
• Cox J, Morissette C, De P, Tremblay C, Allard R, Graves L, , et al Access to sterile injecting equipment is more important than awareness of HCV status for injection risk behaviours among drug users Subs Use Misuse (in press).
   Google Scholar
• Ompad DC, Fuller CM, Vlahov D, Thomas D, Strathdee SA. Lack of behaviour change after disclosure of hepatitis C virus infection among young injection drug users in Baltimore, Maryland. Clin Infect Dis 2002; 35: 783–8
   PubMed Web of Science ®Google Scholar
• Hagan H, Campbell J, Thiede H, Strathdee S, Ouellet L, Kapadia F, et al. Self-reported hepatitis C virus antibody status and risk behaviour in young injectors. Public Health Rep 2006; 121: 710–9
   PubMed Web of Science ®Google Scholar
• Hartel D, Schoenbaum E, Selwyn P, Friedland G, Klein R, Drucker E. Patterns of heroin, cocaine and speedball injection among Bronx (USA) methadone maintenance patients: 1978–1988. Addict Res 1997; 8: 394–404
   Google Scholar
• Burt R. Network items and the general social survey. Soc Networks 1984;6:293–339.
   Web of Science ®Google Scholar
• Hirsch B. Psychological dimensions of social networks: a multi-method analysis. Am J Comm Psychol 1979; 7: 263–77
   Web of Science ®Google Scholar
• Brewer DD, Garrett SB. Evaluation of interviewing techniques to enhance recall of sexual and drug injection partners. Sex Transm Dis 2001; 28: 666–77
   PubMed Web of Science ®Google Scholar
• Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986; 42: 121–30
   PubMed Web of Science ®Google Scholar
• De P, Cox J, Boivin JF, Platt RW, Jolly AM. The importance of social networks in their association to drug equipment sharing among injection drug users: a review. Addiction 2007; 102: 1730–9
   PubMed Web of Science ®Google Scholar
• Racz J, Gyarmathy VA, Neaigus A, Ujhelyi E. Injecting equipment sharing and perception of HIV and hepatitis risk among injecting drug users in Budapest. AIDS Care 2007; 19: 59–66
   PubMed Web of Science ®Google Scholar
• Unger JB, Kipke MD, de Rosa CJ, Hyde J, Ritt-Olson A, Montgomery S. Needle-sharing among young i.v. drug users and their social network members: the influence of the injection partner's characteristics on HIV risk behaviour. Addict Behav 2006; 31: 1607–18
   PubMed Web of Science ®Google Scholar
• Roy E, Nonn E, Haley N, Cox J. Hepatitis C meanings and preventive strategies among street-involved young injection drug users in Montreal. Int J Drug Policy 2007; 18: 397–405
   PubMed Web of Science ®Google Scholar
• Xia Q, Molitor F, Osmond DH, Tholandi M, Pollack LM, Ruiz JD, et al. Knowledge of sexual partner's HIV serostatus and serosorting practices in a California population-based sample of men who have sex with men. Aids 2006; 20: 2081–9
   PubMed Web of Science ®Google Scholar
• Celentano DD, Munoz A, Cohn S, Nelson KE, Vlahov D. Drug-related behaviour change for HIV transmission among American injection drug users. Addiction 1994; 89: 1309–17
   PubMed Web of Science ®Google Scholar
• Ford K, Wirawan DN, Sumantera GM, Sawitri AA, Stahre M. Voluntary HIV testing, disclosure, and stigma among injection drug users in Bali, Indonesia. AIDS Educ Prev 2004; 16: 487–98
   PubMed Web of Science ®Google Scholar
• des Jarlais DC, Perlis T, Arasteh K, Hagan H, Milliken J, Braine N, et al. Informed altruism’ and ‘partner restriction’ in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City. J Acquir Immune Defic Syndr 2004; 35: 158–66
   PubMed Web of Science ®Google Scholar
• Gyarmathy VA, Neaigus A, Ujhelyi E, Szabo T, Racz J. Strong HIV and hepatitis disclosure norms and frequent risk behaviours among Hungarian drug injectors. Drug Alcohol Depend 2006; 82(Suppl 1)S65–9
   Google Scholar
• Best D, Noble A, Finch E, Gossop M, Sidwell C, Strang J. Accuracy of perceptions of hepatitis B and C status: cross-sectional investigation of opiate addicts in treatment. Br Med J 1999; 319: 290–1
   PubMed Web of Science ®Google Scholar
• Shelley G, Bernard H, Killworth P, Johnsen E, McCarty C. Who knows your HIV status? What HIV+ patients and their network members know about each other. Soc Networks 1995; 17: 189–219
   Web of Science ®Google Scholar